Publikationen in Zusammenarbeit mit Forschern von Instituto Maimónides de Investigación Biomédica de Córdoba (1)

2018

  1. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: Possible involvement of different binding sites at the PPARγ receptor

    Journal of Neuroinflammation, Vol. 15, Núm. 1